- Home
- RVP vs QNCX Comparison
RVP vs QNCX Comparison
Compare RVP & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVP | QNCX |
|---|---|---|
| Founded | 1994 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.9M | 19.9M |
| IPO Year | 2000 | 2019 |
Fundamental Metrics
Financial Performance| Metric | RVP | QNCX |
|---|---|---|
| Price | $0.72 | $17.80 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 42.8K | ★ 261.0K |
| Earning Date | 05-14-2026 | 04-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.88 |
| Revenue | ★ $38,266,211.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.08 |
| Revenue Growth | ★ 15.78 | N/A |
| 52 Week Low | $0.60 | $0.08 |
| 52 Week High | $1.14 | $19.26 |
Technical Indicators
Market Signals| Indicator | RVP | QNCX |
|---|---|---|
| Relative Strength Index (RSI) | 56.16 | 89.56 |
| Support Level | $0.62 | $0.89 |
| Resistance Level | $0.74 | $19.26 |
| Average True Range (ATR) | 0.03 | 0.74 |
| MACD | 0.00 | 1.75 |
| Stochastic Oscillator | 75.42 | 90.20 |
Price Performance
Historical ComparisonAbout RVP Retractable Technologies Inc.
Retractable Technologies Inc is engaged in the manufacturing and marketing of safety medical products (predominantly syringes) for the healthcare industry. It has manufacturing facilities in Little Elm, Texas, and uses manufacturers in China as well. Its syringes are well-suited for administering vaccinations. The company's products are VanishPoint Syringe, VanishPoint Insulin Syringes, EasyPoint Needle, EasyPoint Blood Collection Tube with Needle, VanishPoint Blood Collection Set, and VanishPoint IV Catheter. It provides solutions such as Insulin, Immunization, Blood Collection, Allergy, General Purpose, and Infusion.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.